180 Wealth Advisors »

Crispr Therapeutics shares owned by 180 Wealth Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by 180 Wealth Advisors from 13F filings

Historical chart of 180 Wealth Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by 180 Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by 180 Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $205k 4.4k 46.98
2024-06-30 $210k 3.7k 56.81
2022-09-30 $201k 3.1k 65.41